Q01279
Gene name |
Egfr |
Protein name |
Epidermal growth factor receptor |
Names |
EC 2.7.10.1 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:13649 |
EC number |
2.7.10.1: Protein-tyrosine kinases |
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
166-309 (Domain II) |
Relief mechanism |
Partner binding, PTM |
Assay |
|
Accessory elements
856-881 (Activation loop from InterPro)
Target domain |
714-981 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
856-881 (Activation loop from InterPro)
Target domain |
714-981 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
References
- Yeon JH et al. (2016) "Systems-wide Identification of cis-Regulatory Elements in Proteins", Cell systems, 2, 89-100
- Zhang X et al. (2006) "An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor", Cell, 125, 1137-49
- Ferguson KM et al. (2003) "EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization", Molecular cell, 11, 507-17
- Whitson KB et al. (2005) "Functional effects of glycosylation at Asn-579 of the epidermal growth factor receptor", Biochemistry, 44, 14920-31
- Contessa JN et al. (2008) "Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells", Cancer research, 68, 3803-9
- Huang X et al. (2009) "Structural insights into the inhibited states of the Mer receptor tyrosine kinase", Journal of structural biology, 165, 88-96
- Kovacs E et al. (2015) "Analysis of the Role of the C-Terminal Tail in the Regulation of the Epidermal Growth Factor Receptor", Molecular and cellular biology, 35, 3083-102
Autoinhibited structure

Activated structure

1 structures for Q01279
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q01279-F1 | Predicted | AlphaFoldDB |
38 variants for Q01279
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs3389139693 | 23 | G>W | No | EVA | |
rs265991943 | 72 | R>K | No | EVA | |
rs3389137830 | 189 | K>N | No | EVA | |
rs3389155306 | 232 | C>S | No | EVA | |
rs13472485 | 245 | E>D | No | EVA | |
rs13472486 | 247 | D>H | No | EVA | |
rs3389154480 | 266 | P>S | No | EVA | |
rs3389150948 | 310 | A>V | No | EVA | |
rs3389084146 | 317 | E>* | No | EVA | |
rs3412972920 | 324 | R>S | No | EVA | |
rs3389131651 | 397 | T>S | No | EVA | |
rs238953470 | 502 | V>M | No | EVA | |
rs3389143728 | 670 | M>I | No | EVA | |
rs3389150983 | 679 | R>L | No | EVA | |
rs3410235930 | 693 | P>L | No | EVA | |
rs3389143700 | 802 | D>V | No | EVA | |
rs231011417 | 804 | V>I | No | EVA | |
rs3389150944 | 814 | Q>H | No | EVA | |
rs3389108833 | 859 | G>R | No | EVA | |
rs3389139705 | 861 | A>T | No | EVA | |
rs3412928441 | 865 | G>R | No | EVA | |
rs48965927 | 890 | H>L | No | EVA | |
rs3389120339 | 896 | Q>H | No | EVA | |
rs3389131646 | 917 | Y>F | No | EVA | |
rs3412966268 | 946 | Y>* | No | EVA | |
rs3389139726 | 986 | D>N | No | EVA | |
rs3389137750 | 1002 | A>D | No | EVA | |
rs3389155324 | 1016 | D>E | No | EVA | |
rs247870816 | 1064 | A>T | No | EVA | |
rs264415690 | 1076 | A>V | No | EVA | |
rs3389143924 | 1094 | N>D | No | EVA | |
rs3389154432 | 1114 | P>L | No | EVA | |
rs3401939613 | 1130 | S>C | No | EVA | |
rs3413132521 | 1131 | N>I | No | EVA | |
rs3389120368 | 1140 | N>H | No | EVA | |
rs3389139697 | 1142 | A>T | No | EVA | |
rs3389137814 | 1175 | D>A | No | EVA | |
rs3389137838 | 1205 | S>N | No | EVA |
No associated diseases with Q01279
13 regional properties for Q01279
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Receptor L-domain | 57 - 167 | IPR000494-1 |
domain | Receptor L-domain | 362 - 480 | IPR000494-2 |
domain | Protein kinase domain | 714 - 981 | IPR000719 |
domain | Serine-threonine/tyrosine-protein kinase, catalytic domain | 716 - 968 | IPR001245 |
domain | Furin-like cysteine-rich domain | 184 - 338 | IPR006211 |
repeat | Furin-like repeat | 228 - 274 | IPR006212-1 |
repeat | Furin-like repeat | 496 - 601 | IPR006212-2 |
repeat | Furin-like repeat | 614 - 654 | IPR006212-3 |
active_site | Tyrosine-protein kinase, active site | 835 - 847 | IPR008266 |
binding_site | Protein kinase, ATP binding site | 720 - 747 | IPR017441 |
domain | Tyrosine-protein kinase, catalytic domain | 714 - 970 | IPR020635 |
domain | Growth factor receptor domain 4 | 505 - 636 | IPR032778 |
domain | Epidermal growth factor receptor-like, transmembrane-juxtamembrane segment | 648 - 683 | IPR049328 |
Functions
Description | ||
---|---|---|
EC Number | 2.7.10.1 | Protein-tyrosine kinases |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
18 GO annotations of cellular component
Name | Definition |
---|---|
apical plasma membrane | The region of the plasma membrane located at the apical end of the cell. |
basal plasma membrane | The region of the plasma membrane located at the basal end of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
basolateral plasma membrane | The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
cell junction | A cellular component that forms a specialized region of connection between two or more cells, or between a cell and the extracellular matrix, or between two membrane-bound components of a cell, such as flagella. |
cell surface | The external part of the cell wall and/or plasma membrane. |
early endosome membrane | The lipid bilayer surrounding an early endosome. |
endocytic vesicle | A membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance. Endocytic vesicles fuse with early endosomes to deliver the cargo for further sorting. |
endoplasmic reticulum membrane | The lipid bilayer surrounding the endoplasmic reticulum. |
endosome | A vacuole to which materials ingested by endocytosis are delivered. |
Golgi membrane | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
membrane raft | Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. |
multivesicular body, internal vesicle lumen | The volume enclosed by the membrane of the multivesicular body internal vesicle. |
nuclear membrane | Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
receptor complex | Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
ruffle membrane | The portion of the plasma membrane surrounding a ruffle. |
18 GO annotations of molecular function
Name | Definition |
---|---|
actin filament binding | Binding to an actin filament, also known as F-actin, a helical filamentous polymer of globular G-actin subunits. |
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
calmodulin binding | Binding to calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states. |
chromatin binding | Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase. |
epidermal growth factor binding | Binding to epidermal growth factor. |
epidermal growth factor receptor activity | Combining with an epidermal growth factor receptor ligand and transmitting the signal across the plasma membrane to initiate a change in cell activity. |
identical protein binding | Binding to an identical protein or proteins. |
integrin binding | Binding to an integrin. |
kinase activity | Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule. |
protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
protein phosphatase binding | Binding to a protein phosphatase. |
protein tyrosine kinase activity | Catalysis of the reaction |
protein-containing complex binding | Binding to a macromolecular complex. |
signaling receptor binding | Binding to one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
transmembrane receptor protein tyrosine kinase activator activity | Binds to and increases the activity of a transmembrane receptor protein tyrosine kinase. |
transmembrane receptor protein tyrosine kinase activity | Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction |
transmembrane signaling receptor activity | Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction. |
ubiquitin protein ligase binding | Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins. |
80 GO annotations of biological process
Name | Definition |
---|---|
astrocyte activation | A change in morphology and behavior of an astrocyte resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor. |
cell morphogenesis | The developmental process in which the size or shape of a cell is generated and organized. |
cell population proliferation | The multiplication or reproduction of cells, resulting in the expansion of a cell population. |
cell surface receptor signaling pathway | The series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
cell-cell adhesion | The attachment of one cell to another cell via adhesion molecules. |
cellular response to amino acid stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups. |
cellular response to cadmium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus. |
cellular response to dexamethasone stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus. |
cellular response to epidermal growth factor stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epidermal growth factor stimulus. |
cellular response to estradiol stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
cellular response to growth factor stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus. |
cellular response to mechanical stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
cellular response to reactive oxygen species | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals. |
cellular response to xenobiotic stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organism exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. |
cerebral cortex cell migration | The orderly movement of cells from one site to another in the cerebral cortex. |
circadian rhythm | Any biological process in an organism that recurs with a regularity of approximately 24 hours. |
digestive tract morphogenesis | The process in which the anatomical structures of the digestive tract are generated and organized. The digestive tract is the anatomical structure through which food passes and is processed. |
diterpenoid metabolic process | The chemical reactions and pathways involving diterpenoid compounds, terpenoids with four isoprene units. |
embryonic placenta development | The embryonically driven process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin. |
epidermal growth factor receptor signaling pathway | The series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
epidermis development | The process whose specific outcome is the progression of the epidermis over time, from its formation to the mature structure. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species. |
epithelial cell proliferation | The multiplication or reproduction of epithelial cells, resulting in the expansion of a cell population. Epithelial cells make up the epithelium, the covering of internal and external surfaces of the body, including the lining of vessels and other small cavities. It consists of cells joined by small amounts of cementing substances. |
ERBB2-EGFR signaling pathway | The series of molecular signals initiated by binding of a ligand to an epidermal growth factor receptor (EGFR/ERBB1) on the surface of a cell, followed by transmission of the signal by a heterodimeric complex of ERBB2 and EGFR. ERBB2, which does not bind any known ligand, is activated through formation of a heterodimer with another ligand-activated ERBB family member such as EGFR. |
eyelid development in camera-type eye | The progression of the eyelid in a camera-type eye from its formation to the mature state. The eyelid is a membranous cover that helps protect and lubricate the eye. |
hair follicle development | The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open. |
hydrogen peroxide metabolic process | The chemical reactions and pathways involving hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA. |
intracellular signal transduction | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
learning or memory | The acquisition and processing of information and/or the storage and retrieval of this information over time. |
liver regeneration | The regrowth of lost or destroyed liver. |
lung development | The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax. |
midgut development | The process whose specific outcome is the progression of the midgut over time, from its formation to the mature structure. The midgut is the middle part of the alimentary canal from the stomach, or entrance of the bile duct, to, or including, the large intestine. |
morphogenesis of an epithelial fold | The morphogenetic process in which an epithelial sheet bends along a linear axis. |
negative regulation of apoptotic process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
negative regulation of cardiocyte differentiation | Any process that stops, prevents or reduces the frequency, rate or extent of cardiocyte differentiation. |
negative regulation of epidermal growth factor receptor signaling pathway | Any process that stops, prevents, or reduces the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity. |
negative regulation of mitotic cell cycle | Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle. |
negative regulation of protein catabolic process | Any process that stops, prevents or reduces the frequency, rate or extent of protein catabolic process. |
neurogenesis | Generation of cells within the nervous system. |
neuron projection morphogenesis | The process in which the anatomical structures of a neuron projection are generated and organized. A neuron projection is any process extending from a neural cell, such as axons or dendrites. |
ovulation cycle | The type of sexual cycle seen in females, often with physiologic changes in the endometrium that recur at regular intervals during the reproductive years. |
phosphorylation | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. |
positive regulation of bone resorption | Any process that activates or increases the frequency, rate or extent of bone resorption. |
positive regulation of canonical Wnt signaling pathway | Any process that increases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. |
positive regulation of cell growth | Any process that activates or increases the frequency, rate, extent or direction of cell growth. |
positive regulation of cell migration | Any process that activates or increases the frequency, rate or extent of cell migration. |
positive regulation of cell population proliferation | Any process that activates or increases the rate or extent of cell proliferation. |
positive regulation of DNA repair | Any process that activates or increases the frequency, rate or extent of DNA repair. |
positive regulation of DNA replication | Any process that activates or increases the frequency, rate or extent of DNA replication. |
positive regulation of epithelial cell proliferation | Any process that activates or increases the rate or extent of epithelial cell proliferation. |
positive regulation of ERK1 and ERK2 cascade | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
positive regulation of fibroblast proliferation | Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells. |
positive regulation of G1/S transition of mitotic cell cycle | Any signalling pathway that increases or activates a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the mitotic cell cycle. |
positive regulation of glial cell proliferation | Any process that activates or increases the rate or extent of glial cell proliferation. |
positive regulation of MAPK cascade | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade. |
positive regulation of miRNA transcription | Any process that activates or increases the frequency, rate or extent of microRNA (miRNA) gene transcription. |
positive regulation of mucus secretion | Any process that activates or increases the frequency, rate or extent of the regulated release of mucus from a cell or a tissue. |
positive regulation of non-canonical NF-kappaB signal transduction | Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling. |
positive regulation of peptidyl-serine phosphorylation | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
positive regulation of prolactin secretion | Any process that activates or increases the frequency, rate or extent of prolactin secretion. |
positive regulation of protein localization to early endosome | Any process that activates or increases the frequency, rate or extent of protein localization to early endosome. |
positive regulation of protein localization to plasma membrane | Any process that activates or increases the frequency, rate or extent of protein localization to plasma membrane. |
positive regulation of protein phosphorylation | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
positive regulation of smooth muscle cell proliferation | Any process that activates or increases the rate or extent of smooth muscle cell proliferation. |
positive regulation of superoxide anion generation | Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell. |
positive regulation of synaptic transmission, glutamatergic | Any process that activates, maintains or increases the frequency, rate or extent of glutamatergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate. |
positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
positive regulation of vasoconstriction | Any process that activates or increases the frequency, rate or extent of vasoconstriction. |
regulation of cell population proliferation | Any process that modulates the frequency, rate or extent of cell proliferation. |
regulation of JNK cascade | Any process that modulates the frequency, rate or extent of signal transduction mediated by the JNK cascade. |
regulation of peptidyl-tyrosine phosphorylation | Any process that modulates the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
response to calcium ion | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus. |
response to cobalamin | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cobalamin (vitamin B12) stimulus. |
response to hydroxyisoflavone | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydroxyisoflavone stimulus. |
response to UV-A | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a UV-A radiation stimulus. UV-A radiation (UV-A light) spans the wavelengths 315 to 400 nm. |
salivary gland morphogenesis | The process in which the anatomical structures of the salivary gland are generated and organized. |
signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
tongue development | The process whose specific outcome is the progression of the tongue over time, from its formation to the mature structure. The tongue is the movable, muscular organ on the floor of the mouth of most vertebrates, in many other mammals is the principal organ of taste, aids in the prehension of food, in swallowing, and in modifying the voice as in speech. |
translation | The cellular metabolic process in which a protein is formed, using the sequence of a mature mRNA or circRNA molecule to specify the sequence of amino acids in a polypeptide chain. Translation is mediated by the ribosome, and begins with the formation of a ternary complex between aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, which subsequently associates with the small subunit of the ribosome and an mRNA or circRNA. Translation ends with the release of a polypeptide chain from the ribosome. |
vasodilation | An increase in the internal diameter of blood vessels, especially arterioles or capillaries, due to relaxation of smooth muscle cells that line the vessels, and usually resulting in a decrease in blood pressure. |
54 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
P13387 | EGFR | Epidermal growth factor receptor | Gallus gallus (Chicken) | SS |
P04626 | ERBB2 | Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (Human) | SS |
P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (Human) | SS |
Q15303 | ERBB4 | Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (Human) | SS |
P00533 | EGFR | Epidermal growth factor receptor | Homo sapiens (Human) | EV |
P70424 | Erbb2 | Receptor tyrosine-protein kinase erbB-2 | Mus musculus (Mouse) | SS |
Q61526 | Erbb3 | Receptor tyrosine-protein kinase erbB-3 | Mus musculus (Mouse) | SS |
Q01887 | Ryk | Tyrosine-protein kinase RYK | Mus musculus (Mouse) | PR |
P35546 | Ret | Proto-oncogene tyrosine-protein kinase receptor Ret | Mus musculus (Mouse) | SS |
Q61006 | Musk | Muscle, skeletal receptor tyrosine-protein kinase | Mus musculus (Mouse) | SS |
Q9Z138 | Ror2 | Tyrosine-protein kinase transmembrane receptor ROR2 | Mus musculus (Mouse) | SS |
Q9Z139 | Ror1 | Inactive tyrosine-protein kinase transmembrane receptor ROR1 | Mus musculus (Mouse) | PR |
Q62371 | Ddr2 | Discoidin domain-containing receptor 2 | Mus musculus (Mouse) | SS |
Q03146 | Ddr1 | Epithelial discoidin domain-containing receptor 1 | Mus musculus (Mouse) | SS |
P15209 | Ntrk2 | BDNF/NT-3 growth factors receptor | Mus musculus (Mouse) | SS |
Q3UFB7 | Ntrk1 | High affinity nerve growth factor receptor | Mus musculus (Mouse) | SS |
Q6VNS1 | Ntrk3 | NT-3 growth factor receptor | Mus musculus (Mouse) | SS |
P35917 | Flt4 | Vascular endothelial growth factor receptor 3 | Mus musculus (Mouse) | SS |
P35969 | Flt1 | Vascular endothelial growth factor receptor 1 | Mus musculus (Mouse) | SS |
P35918 | Kdr | Vascular endothelial growth factor receptor 2 | Mus musculus (Mouse) | PR |
Q03145 | Epha2 | Ephrin type-A receptor 2 | Mus musculus (Mouse) | PR |
Q60750 | Epha1 | Ephrin type-A receptor 1 | Mus musculus (Mouse) | SS |
P54761 | Ephb4 | Ephrin type-B receptor 4 | Mus musculus (Mouse) | PR |
Q60629 | Epha5 | Ephrin type-A receptor 5 | Mus musculus (Mouse) | SS |
P97793 | Alk | ALK tyrosine kinase receptor | Mus musculus (Mouse) | SS |
Q9WTL4 | Insrr | Insulin receptor-related protein | Mus musculus (Mouse) | SS |
Q60751 | Igf1r | Insulin-like growth factor 1 receptor | Mus musculus (Mouse) | SS |
P15208 | Insr | Insulin receptor | Mus musculus (Mouse) | SS |
P16092 | Fgfr1 | Fibroblast growth factor receptor 1 | Mus musculus (Mouse) | SS |
P21803 | Fgfr2 | Fibroblast growth factor receptor 2 | Mus musculus (Mouse) | SS |
Q03142 | Fgfr4 | Fibroblast growth factor receptor 4 | Mus musculus (Mouse) | PR |
Q60805 | Mertk | Tyrosine-protein kinase Mer | Mus musculus (Mouse) | SS |
Q62190 | Mst1r | Macrophage-stimulating protein receptor | Mus musculus (Mouse) | SS |
Q00993 | Axl | Tyrosine-protein kinase receptor UFO | Mus musculus (Mouse) | PR |
P55144 | Tyro3 | Tyrosine-protein kinase receptor TYRO3 | Mus musculus (Mouse) | SS |
Q61527 | Erbb4 | Receptor tyrosine-protein kinase erbB-4 | Mus musculus (Mouse) | SS |
Q02858 | Tek | Angiopoietin-1 receptor | Mus musculus (Mouse) | SS |
Q06806 | Tie1 | Tyrosine-protein kinase receptor Tie-1 | Mus musculus (Mouse) | SS |
P05532 | Kit | Mast/stem cell growth factor receptor Kit | Mus musculus (Mouse) | PR |
P05622 | Pdgfrb | Platelet-derived growth factor receptor beta | Mus musculus (Mouse) | SS |
P09581 | Csf1r | Macrophage colony-stimulating factor 1 receptor | Mus musculus (Mouse) | SS |
P26618 | Pdgfra | Platelet-derived growth factor receptor alpha | Mus musculus (Mouse) | SS |
Q00342 | Flt3 | Receptor-type tyrosine-protein kinase FLT3 | Mus musculus (Mouse) | SS |
Q61851 | Fgfr3 | Fibroblast growth factor receptor 3 | Mus musculus (Mouse) | PR |
P16056 | Met | Hepatocyte growth factor receptor | Mus musculus (Mouse) | PR |
Q62799 | Erbb3 | Receptor tyrosine-protein kinase erbB-3 | Rattus norvegicus (Rat) | SS |
Q62956 | Erbb4 | Receptor tyrosine-protein kinase erbB-4 | Rattus norvegicus (Rat) | SS |
P06494 | Erbb2 | Receptor tyrosine-protein kinase erbB-2 | Rattus norvegicus (Rat) | SS |
P55245 | EGFR | Epidermal growth factor receptor | Macaca mulatta (Rhesus macaque) | SS |
O16262 | nipi-4 | Protein nipi-4 | Caenorhabditis elegans | PR |
Q9LMN7 | WAK5 | Wall-associated receptor kinase 5 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q9LSV3 | WAKL16 | Putative wall-associated receptor kinase-like 16 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q9M342 | WAKL15 | Wall-associated receptor kinase-like 15 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q8VZJ9 | CRCK2 | Calmodulin-binding receptor-like cytoplasmic kinase 2 | Arabidopsis thaliana (Mouse-ear cress) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MRPSGTARTT | LLVLLTALCA | AGGALEEKKV | CQGTSNRLTQ | LGTFEDHFLS | LQRMYNNCEV |
70 | 80 | 90 | 100 | 110 | 120 |
VLGNLEITYV | QRNYDLSFLK | TIQEVAGYVL | IALNTVERIP | LENLQIIRGN | ALYENTYALA |
130 | 140 | 150 | 160 | 170 | 180 |
ILSNYGTNRT | GLRELPMRNL | QEILIGAVRF | SNNPILCNMD | TIQWRDIVQN | VFMSNMSMDL |
190 | 200 | 210 | 220 | 230 | 240 |
QSHPSSCPKC | DPSCPNGSCW | GGGEENCQKL | TKIICAQQCS | HRCRGRSPSD | CCHNQCAAGC |
250 | 260 | 270 | 280 | 290 | 300 |
TGPRESDCLV | CQKFQDEATC | KDTCPPLMLY | NPTTYQMDVN | PEGKYSFGAT | CVKKCPRNYV |
310 | 320 | 330 | 340 | 350 | 360 |
VTDHGSCVRA | CGPDYYEVEE | DGIRKCKKCD | GPCRKVCNGI | GIGEFKDTLS | INATNIKHFK |
370 | 380 | 390 | 400 | 410 | 420 |
YCTAISGDLH | ILPVAFKGDS | FTRTPPLDPR | ELEILKTVKE | ITGFLLIQAW | PDNWTDLHAF |
430 | 440 | 450 | 460 | 470 | 480 |
ENLEIIRGRT | KQHGQFSLAV | VGLNITSLGL | RSLKEISDGD | VIISGNRNLC | YANTINWKKL |
490 | 500 | 510 | 520 | 530 | 540 |
FGTPNQKTKI | MNNRAEKDCK | AVNHVCNPLC | SSEGCWGPEP | RDCVSCQNVS | RGRECVEKCN |
550 | 560 | 570 | 580 | 590 | 600 |
ILEGEPREFV | ENSECIQCHP | ECLPQAMNIT | CTGRGPDNCI | QCAHYIDGPH | CVKTCPAGIM |
610 | 620 | 630 | 640 | 650 | 660 |
GENNTLVWKY | ADANNVCHLC | HANCTYGCAG | PGLQGCEVWP | SGPKIPSIAT | GIVGGLLFIV |
670 | 680 | 690 | 700 | 710 | 720 |
VVALGIGLFM | RRRHIVRKRT | LRRLLQEREL | VEPLTPSGEA | PNQAHLRILK | ETEFKKIKVL |
730 | 740 | 750 | 760 | 770 | 780 |
GSGAFGTVYK | GLWIPEGEKV | KIPVAIKELR | EATSPKANKE | ILDEAYVMAS | VDNPHVCRLL |
790 | 800 | 810 | 820 | 830 | 840 |
GICLTSTVQL | ITQLMPYGCL | LDYVREHKDN | IGSQYLLNWC | VQIAKGMNYL | EDRRLVHRDL |
850 | 860 | 870 | 880 | 890 | 900 |
AARNVLVKTP | QHVKITDFGL | AKLLGAEEKE | YHAEGGKVPI | KWMALESILH | RIYTHQSDVW |
910 | 920 | 930 | 940 | 950 | 960 |
SYGVTVWELM | TFGSKPYDGI | PASDISSILE | KGERLPQPPI | CTIDVYMIMV | KCWMIDADSR |
970 | 980 | 990 | 1000 | 1010 | 1020 |
PKFRELILEF | SKMARDPQRY | LVIQGDERMH | LPSPTDSNFY | RALMDEEDME | DVVDADEYLI |
1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
PQQGFFNSPS | TSRTPLLSSL | SATSNNSTVA | CINRNGSCRV | KEDAFLQRYS | SDPTGAVTED |
1090 | 1100 | 1110 | 1120 | 1130 | 1140 |
NIDDAFLPVP | EYVNQSVPKR | PAGSVQNPVY | HNQPLHPAPG | RDLHYQNPHS | NAVGNPEYLN |
1150 | 1160 | 1170 | 1180 | 1190 | 1200 |
TAQPTCLSSG | FNSPALWIQK | GSHQMSLDNP | DYQQDFFPKE | TKPNGIFKGP | TAENAEYLRV |
APPSSEFIGA |